Haddadin Yezan Munther

EDGAR CIK 0001718004

Outlook Therapeutics, Inc. - OTLK

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
1
$22,233
1,881 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/28/2024
03/29/2024
Buy
1,881 @ $11.82
 $22,233 5,049 (59.38%) Direct